CPT code 62282 designates an interventional pain management procedure: injection or infusion of a neurolytic agent into the lumbar or sacral epidural space, sometimes combined with another therapeutic drug. The code is used for targeted neurolysis to relieve severe pain from nerve root compression, complex recurrent postoperative pain, or spasm related to spasticity or paraplegia. Nationally, this code matters because it captures high-acuity, procedure-driven pain control interventions that can affect utilization, site-of-care decisions, and payer coverage policies.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical intent and expected sites of service, plus benchmarking and policy context where available. The publication highlights typical billing considerations, common modifiers supplied in the input, and implications for coding accuracy and claims processing.

This summary prepares clinicians, coders, and policy professionals to understand where CPT code 62282 fits within interventional pain services, what clinical indications it supports, and what to expect in payer coverage and administrative handling at a national level. Data not available in the input are identified where applicable in supporting sections.